Apricity Therapeutics Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$168K
- Investors
-
6
Apricity Therapeutics General Information
Description
Developer of exploit solute carrier transporter platform for pushing chemotherapy agents directly to tumors intended to treat pediatric cancers. The company is building a solute carrier transporter platform to improve drug pharmacological effects, reduce drug toxicity, and target transporters, enabling patients to get better treatments.
Contact Information
Corporate Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
Apricity Therapeutics Timeline
Apricity Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Grant | 01-Jan-2022 | $168K | Completed | Startup | ||
| 11. Grant | 31-Dec-2020 | 00000 | Completed | Startup | ||
| 10. Grant | 31-Dec-2020 | 00000 | Completed | Startup | ||
| 9. Grant | 01-Sep-2020 | 00000 | Completed | Startup | ||
| 8. Grant | 01-Jan-2019 | 00000 | Completed | Startup | ||
| 7. Grant | 17-May-2017 | 00000 | Completed | Startup | ||
| 6. Grant | 01-Jan-2017 | 00000 | Completed | Startup | ||
| 5. Grant | 01-Jan-2016 | 00000 | Completed | Startup | ||
| 4. Grant | 01-Jan-2014 | $190K | Completed | Startup | ||
| 3. Accelerator/Incubator | 19-Sep-2012 | Completed | Startup |
Apricity Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Apricity Therapeutics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Kathleen Giacomini Ph.D | Co-Founder, Co-Owner & Scientific Advisor |
Apricity Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Apricity Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| U.S. Food and Drug Administration | Government | 000 0000 | 000000 0 | ||
| National Institute of General Medical Sciences | Government | 000 0000 | 000000 0 | ||
| QB3 | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| National Cancer Institute | Government | 000 0000 | 000000 0 |
Apricity Therapeutics FAQs
-
When was Apricity Therapeutics founded?
Apricity Therapeutics was founded in 2012.
-
Who is the founder of Apricity Therapeutics?
Ethan Geier Ph.D, Sook Wah Yee, and Kathleen Giacomini Ph.D are the founders of Apricity Therapeutics.
-
Where is Apricity Therapeutics headquartered?
Apricity Therapeutics is headquartered in San Francisco, CA.
-
What is the size of Apricity Therapeutics?
Apricity Therapeutics has 2 total employees.
-
What industry is Apricity Therapeutics in?
Apricity Therapeutics’s primary industry is Biotechnology.
-
Is Apricity Therapeutics a private or public company?
Apricity Therapeutics is a Private company.
-
What is Apricity Therapeutics’s current revenue?
The current revenue for Apricity Therapeutics is 000000.
-
Who are Apricity Therapeutics’s investors?
U.S. Department of Health and Human Services, U.S. Food and Drug Administration, National Institute of General Medical Sciences, QB3, and National Cancer Institute are 5 of 6 investors who have invested in Apricity Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
